News
In a major advancement for global HIV prevention, the World Health Organisation (WHO) has officially recommended injectable ...
Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc. (NASDAQ:GILD) has received a favorable opinion from the European Medicines ...
The Herald on MSN4d
Yeztugo: Life-saving HIV prevention injection costs $28,000 a year
Gilead Sciences has secured approval from the United States health authorities for its new HIV prevention injection, Yeztugo, but concerns are growing over its steep price tag.
A potential breakthrough in the ongoing AIDS crisis could be deprioritized due to the decisions of noted vaccine skeptic Robert F. Kennedy, Jr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback